The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Healthcare resource utilization (HCRU), costs, and mortality in relation to select immune-related adverse events (irAEs) and line of therapy (LOT) in patients (pts) with advanced or metastatic urothelial cancer (UC) treated with immune checkpoint inhibitor (ICI) monotherapy.
 
Saby George
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Eisai; EMD Serono; Exelixis; Merck; Pfizer; Sanofi; Seattle Genetics/Astellas
Research Funding - Agensys (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Ying Zheng
Employment - EMD Serono; Takeda (I)
Stock and Other Ownership Interests - EMD Serono; Takeda (I)
Patents, Royalties, Other Intellectual Property - Takeda (I)
 
Elizabeth Bell
Employment - Optum/UnitedHealth Group
Research Funding - AstraZeneca; Celgene; EMD Serono; Incyte; Novartis; Sandoz
 
Nicole Engel-Nitz
Employment - Optum/UnitedHealth Group
Stock and Other Ownership Interests - United Health Group
Research Funding - Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Exact Sciences (Inst); Genentech (Inst); GlaxoSmithKline (Inst)
 
John C White
Employment - Optum
Research Funding - EMD Serono (Inst); Optum (Inst)
 
Lincy S. Lal
Employment - Optum
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Celgene (Inst); CLovis Oncology (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Novartis (Inst); Sandoz (Inst); Vertex (Inst)
 
Mo Yang
Employment - EMD Serono
 
Geeta Devgan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jodi Smith
Employment - EMD Serono
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
 
Ruth Kim
Employment - Pfizer
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation; Exelixis
Research Funding - Pfizer
 
Frank Xiaoqing Liu
Employment - EMD Serono
Stock and Other Ownership Interests - EMD Serono; Merck
Research Funding - EMD Serono